A detailed history of Anchor Investment Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Anchor Investment Management, LLC holds 858 shares of REGN stock, worth $647,678. This represents 0.09% of its overall portfolio holdings.

Number of Shares
858
Previous 275 212.0%
Holding current value
$647,678
Previous $289 Million 212.06%
% of portfolio
0.09%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

BUY
$1024.09 - $1201.76 $597,044 - $700,626
583 Added 212.0%
858 $902 Million
Q2 2024

Sep 20, 2024

SELL
$883.2 - $1071.19 $1.05 Million - $1.27 Million
-1,185 Reduced 81.16%
275 $289 Million
Q1 2024

May 15, 2024

BUY
$902.69 - $993.35 $72,215 - $79,468
80 Added 5.8%
1,460 $1.41 Billion
Q4 2023

Jan 02, 2024

BUY
$775.18 - $881.7 $1.07 Million - $1.22 Million
1,380 New
1,380 $1.21 Billion
Q3 2023

Jan 02, 2024

BUY
$692.45 - $844.37 $116,331 - $141,854
168 Added 16.29%
1,199 $987 Million
Q2 2023

Jan 02, 2024

BUY
$700.03 - $830.35 $182,707 - $216,721
261 Added 33.9%
1,031 $741 Million
Q1 2023

Jan 02, 2024

BUY
$680.49 - $826.97 $25,858 - $31,424
38 Added 5.19%
770 $633 Million
Q4 2022

Jan 02, 2024

SELL
$705.89 - $766.39 $457,416 - $496,620
-648 Reduced 46.96%
732 $528 Million
Q3 2022

Jan 02, 2024

SELL
$573.97 - $724.32 $184,244 - $232,506
-321 Reduced 23.26%
1,059 $730 Million
Q2 2022

Jan 02, 2024

BUY
$548.35 - $738.84 $27,417 - $36,942
50 Added 5.81%
910 $538 Million
Q1 2022

Jan 02, 2024

BUY
$595.12 - $698.43 $50,585 - $59,366
85 Added 10.97%
860 $601 Million
Q4 2021

Jan 02, 2024

BUY
$543.48 - $670.97 $98,913 - $122,116
182 Added 30.69%
775 $489 Million
Q3 2021

Jan 02, 2024

SELL
$574.03 - $680.96 $451,761 - $535,915
-787 Reduced 57.03%
593 $359 Million
Q2 2021

Jan 02, 2024

SELL
$472.8 - $558.54 $104,488 - $123,437
-221 Reduced 24.53%
680 $380 Million
Q1 2021

Jan 02, 2024

BUY
$446.73 - $548.2 $368,998 - $452,813
826 Added 1101.33%
901 $426 Million
Q4 2020

Jan 02, 2024

BUY
$478.3 - $607.98 $16,740 - $21,279
35 Added 87.5%
75 $36.2 Million
Q3 2020

Jan 02, 2024

SELL
$544.75 - $658.21 $729,965 - $882,001
-1,340 Reduced 97.1%
40 $22.4 Million
Q4 2019

Jan 02, 2024

SELL
$274.13 - $376.51 $2,741 - $3,765
-10 Closed
0 $0
Q3 2019

Jan 02, 2024

SELL
$273.46 - $318.39 $374,640 - $436,194
-1,370 Reduced 99.28%
10 $2.77 Million
Q2 2019

Jan 02, 2024

SELL
$299.6 - $414.82 $7,490 - $10,370
-25 Reduced 71.43%
10 $3.13 Million
Q1 2019

Jan 02, 2024

BUY
$372.08 - $439.57 $9,302 - $10,989
25 Added 250.0%
35 $14.4 Million
Q3 2018

Jan 02, 2024

SELL
$351.14 - $408.51 $481,061 - $559,658
-1,370 Reduced 99.28%
10 $4.04 Million
Q2 2018

Jan 03, 2024

SELL
$284.6 - $344.99 $389,902 - $472,636
-1,370 Reduced 99.28%
10 $3.45 Million
Q1 2018

Jan 03, 2024

BUY
$315.82 - $393.78 $102,325 - $127,584
324 Added 1012.5%
356 $123 Million
Q4 2017

Jan 03, 2024

BUY
$358.63 - $469.95 $2,510 - $3,289
7 Added 28.0%
32 $12 Million
Q3 2017

Jan 03, 2024

SELL
$431.38 - $504.0 $584,519 - $682,920
-1,355
25 $11.2 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Anchor Investment Management, LLC Portfolio

Follow Anchor Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.